CNS dopamine autoreceptors: distribution, pharmacology, and function.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D015107:4-Butyrolactone / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D002147:Calmodulin / Q000378:metabolism; D004298:Dopamine / Q000502:physiology; D018492:Dopamine Antagonists; D004361:Drug Tolerance; D004594:Electrophysiology; D006719:Homovanillic Acid / Q000378:metabolism; D008032:Limbic System / Q000502:physiology; D008636:Mesencephalon / Q000502:physiology; D008745:Methylation; D008781:Methyltyrosines / Q000494:pharmacology; D009474:Neurons / Q000502:physiology; D011954:Receptors, Dopamine / Q000502:physiology*; D013312:Stress, Physiological / Q000503:physiopathology; D013687:Telencephalon / Q000502:physiology; D014018:Tissue Distribution; D019805:alpha-Methyltyrosine
D002147:Calmodulin; D018492:Dopamine Antagonists; D008781:Methyltyrosines; D011954:Receptors, Dopamine; D015102:3,4-Dihydroxyphenylacetic Acid; D019805:alpha-Methyltyrosine; D001058:Apomorphine; D015107:4-Butyrolactone; D004298:Dopamine; D006719:Homovanillic Acid